RFK Jr. may start a food and drug 'culture war.' Investors are running for cover.
President-elect Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services is one of several unorthodox appointments rolled out in recent weeks, and ...
BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health ...
Hosted on MSN15h
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Donald Trump's appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences ...